Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea

• Published in: Cancer research and treatment Vol. 53; no. 2; pp. 323 - 329
• Main Authors: Lee, Jii Bum, Jung, Minkyu, Kim, June Hyuk, Kim, Bo Hyun, Kim, Yeol, Kim, Young Seok, Kim, Byung Chang, Kim, Jin, Moon, Sung Ho, Park, Keon-Uk, Park, Meerim, Park, Hyeon Jin, Sim, Sung Hoon, Yoon, Hong Man, Lee, Soo Jung, Lee, Eunyoung, Chun, June Young, Chung, Youn Kyung, Jung, So-Youn, Chung, Jinsoo, Lee, Eun Sook, Chung, Hyun Cheol, Yun, Tak, Rha, Sun Young
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Cancer Association 01.04.2021; 대한암학회
• Subjects: Clinical Trials as Topic; COVID-19; Early Detection of Cancer; Humans; Medical Oncology - standards; Neoplasms - therapy; Patient Safety; Practice Guidelines as Topic; Republic of Korea; Special; 의학일반; Republic of Korea; COVID-19; Cancer care; Guideline; Korea
• ISSN: 1598-2998; 2005-9256; 2005-9256
• DOI: 10.4143/crt.2020.1256

At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.